1. Home
  2. NSP vs CMPX Comparison

NSP vs CMPX Comparison

Compare NSP & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Insperity Inc.

NSP

Insperity Inc.

HOLD

Current Price

$26.50

Market Cap

819.5M

ML Signal

HOLD

Logo Compass Therapeutics Inc.

CMPX

Compass Therapeutics Inc.

HOLD

Current Price

$5.23

Market Cap

927.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NSP
CMPX
Founded
1986
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
819.5M
927.5M
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
NSP
CMPX
Price
$26.50
$5.23
Analyst Decision
Hold
Strong Buy
Analyst Count
3
9
Target Price
$47.67
$14.43
AVG Volume (30 Days)
1.1M
1.7M
Earning Date
04-28-2026
03-05-2026
Dividend Yield
8.95%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$6,812,000,000.00
N/A
Revenue This Year
$3.45
N/A
Revenue Next Year
$6.95
$677.91
P/E Ratio
N/A
N/A
Revenue Growth
3.51
N/A
52 Week Low
$18.57
$1.33
52 Week High
$90.63
$6.88

Technical Indicators

Market Signals
Indicator
NSP
CMPX
Relative Strength Index (RSI) 54.73 41.55
Support Level $18.57 $4.86
Resistance Level $48.91 $5.86
Average True Range (ATR) 1.72 0.29
MACD 1.15 0.01
Stochastic Oscillator 84.65 36.26

Price Performance

Historical Comparison
NSP
CMPX

About NSP Insperity Inc.

Insperity Inc is a company that provides a wide range of human resources and business solutions designed to help businesses improve their performance. Small and midsize enterprises are the company's primary target customers. Majority of the company's products are offered through the company's Workforce Optimization and Workforce Synchronization solutions, which comprise various human resource functions, such as payroll and employment administration, employee benefits and compensation, government compliance, performance management, training and development services, and human capital management. The company generates all of its revenue in the United States.

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to target the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-A, Bispecific, and CTX-8371.

Share on Social Networks: